| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Goodman Noah is a Chief Business Officer at KYMR. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $5.4M at current prices.
Goodman Noah's largest disclosed position is in KYMR as Chief Business Officer, worth about $5.4M. The recent filings there lean toward selling, a net 22,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Business Officer | Sell10b5-1 | 3,389 | $114.29 | $387,328.81 | -6.7% | -3.2% | - | |
| Jun 25, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Business Officer | Sale+OE10b5-1 | 5,000 | $114.00 | $570,000.00 | -9.1% | -0.9% | - | |
| Jun 22, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Business Officer | Sale+OE10b5-1 | 2,500 | $99.00 | $247,500.00 | -4.7% | +18.3% | - | |
| Apr 14, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Business Officer | Sell10b5-1 | 1,347 | $90.00 | $121,230.00 | -2.6% | +22.9% | - | |
| Apr 10, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Business Officer | Sale+OE10b5-1 | 10,264 | $87.47 | $897,782.20 | -16.6% | +39.9% | - |